Overview

Early Diagnosis of Diastolic Dysfunction and Reliability of DSE in Detecting Stress Diastolic Dysfunction

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
The heart becoming "stiff" due to increased fibrous tissue or decreased elasticity of the heart tissue is one of the earliest changes caused by heart failure. These changes can be detected by simple non-invasive echocardiogram techniques. However, these techniques usually detect the increased "stiffness" of the heart only after it has progressed to a significant extent. The investigators hypothesize that if they stress the heart using a Dobutamine infusion and measure the filling pressure using echocardiogram, it will provide them with tools to identify these changes earlier.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Missouri-Columbia
Collaborators:
Kansas City Veteran Affairs Medical Center
Veterans Administration, Kansas City
Treatments:
Atropine
Dobutamine
Criteria
Inclusion Criteria:

- Prospectively enroll 25 veterans age range from 18 to 65 who are found to have normal
left ventricular (LV) systolic function and no significant coronary artery disease by
cardiac catheterization.

- Subjects identified during routine cardiac testing to have significant diastolic
dysfunction may also be enrolled to rule out coronary disease and study DSE -invasive
pressure correlations.

Exclusion criteria:

- Patients with LV systolic dysfunction, severe coronary lesions (> 50%), uncontrolled
hypertension (BP > 160/100) and significant pulmonary hypertension (PASP > 50 mmHg)
would be excluded.

- Subject will not be included if they have a significant rhythm abnormality, frequent
premature ventricular complexes, atrial fibrillation and technical reasons in the
catheterization laboratory which preclude the study protocol.